Their management is setting up a good offering price, which is alright

No scam here, just great science, great fiscal Management and a CEO fixated on precision rather than stock price.

Management has done nothing wrong.

The logical and much more direct conclusion is that management is telling the truth and that Blarcamesine is an extraordinarily promising compound the very likely will become a Blockbuster approved drug in the future.

$AVXL at such a bargain price, zero open market buy from the management tells you all you need to know.

$AVXL Beyond Bullish, downright crazy for the stock, the drug, the management, the whole damn company.

$BCRX Despite the fair critiques of kicking the can down the road so to speak, management is doing the right thing.

Still a believer in the company and management and the trajectory they are aiming for.

I believe in the science and the management here which is pretty rare.

But, with our management, our scientists, and our derisked ORLADEYO keeping the revenues incoming and growing quarter after quarter after quarter.

BIOCRYST has increasing revenues, great scientists, a damned good management, and a pipeline (some public, some not).

I bet their mgmt kills it with only positive surprises this time.

Management is good.

Oh great management.

$BCRX Love this company and love this management team.

Not going anywhere, still a strong believer in the products and management team.

A competitor to Hubspot with excellent management and a massive growth runway.